Gravar-mail: RTRB-01 UTILIZING THE GENOMICALLY ADJUSTED DOSE (GAD) TO IDENTIFY PATIENTS FOR ADJUVANT RADIATION DOSE ESCALATION IN GLIOBLASTOMA